Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography
暂无分享,去创建一个
Stephanie Ringeissen | Paul McGill | Brian C Sweatman | Susan C Connor | M. Hodson | S. Connor | B. Sweatman | J. Haselden | C. Waterfield | D. Nunez | R. Haworth | John N Haselden | Catherine J Waterfield | Mark P Hodson | M. Aylott | H Roger Brown | Steve P Kenny | Richard I Haworth | Mark A Price | Mike C Aylott | Derek J Nunez | Mike C. Aylott | H. R. Brown | P. McGill | M. Price | Steve P. Kenny | S. Ringeissen | Michael C. Aylott
[1] Y. Nishizuka,et al. STUDIES ON THE BIOSYNTHESIS OF NICOTINAMIDE ADENINE DINUCLEOTIDE. II. A ROLE OF PICOLINIC CARBOXYLASE IN THE BIOSYNTHESIS OF NICOTINAMIDE ADENINE DINUCLEOTIDE FROM TRYPTOPHAN IN MAMMALS. , 1965, The Journal of biological chemistry.
[2] P Grasso,et al. Hepatic peroxisome proliferation in rodents and its significance for humans. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[3] S. Yuyama,et al. Isolation and identification of N1-methylnicotinic acid (trigonelline) from rat urine. , 1985, Journal of nutritional science and vitaminology.
[4] J. Styles,et al. Mitosis and histopathology in rat liver during methylclofenapate-induced hyperplasia. , 1990, Cancer Letters.
[5] S Kettle,et al. Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.
[6] N. Lalwani,et al. Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent. , 1985, Biochemical pharmacology.
[7] K. Shibata,et al. Niacin catabolism in rodents. , 1990, Journal of nutritional science and vitaminology.
[8] C. Elcombe,et al. Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte Cultures , 1996, Annals of the New York Academy of Sciences.
[9] E. Ros,et al. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver , 2002, Clinical pharmacology and therapeutics.
[10] S. Wold,et al. Orthogonal signal correction of near-infrared spectra , 1998 .
[11] B. Lake. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. , 1995, Toxicology letters.
[12] C. Bernofsky. New synthesis of the 4- and 6-pyridones of 1-methylnicotinamide and 1-methylnicotinic acid (trigonelline). , 1979, Analytical biochemistry.
[13] K. Beier. Light microscopic morphometric analysis of peroxisomes by automatic image analysis: advantages of immunostaining over the alkaline DAB method. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[14] Y. Egashira,et al. Change of tryptophan-niacin metabolism in D-galactosamine-induced liver injury in rat. , 1997, Journal of nutritional science and vitaminology.
[15] C Kemmer,et al. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. , 1983, Atherosclerosis.
[16] K. Shibata,et al. Influence of Adenine-induced Renal Failure on Tryptophan-niacin Metabolism in Rats , 2001, Bioscience, biotechnology, and biochemistry.
[17] M. Hollinshead,et al. Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment. , 1988, European journal of cell biology.
[18] Y. Egashira,et al. Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes. , 2002, The Journal of nutrition.
[19] R. Gholson,et al. Isolation and identification of two new nicotinamide metabolites. , 1969, The Journal of biological chemistry.
[20] R. Cuomo,et al. Nicotinamide methylation and hepatic energy reserve: a study by liver perfusion in vitro. , 1995, Journal of hepatology.
[21] J. Nicholson,et al. Hepatotoxin-induced hypertaurinuria: a proton NMR study , 2005, Archives of Toxicology.
[22] M. Shin,et al. NAD+ biosynthesis and metabolic fluxes of tryptophan in hepatocytes isolated from rats fed a clofibrate-containing diet. , 1996, Biochemical pharmacology.
[23] B. Ledwith,et al. Peroxisome proliferators activate growth regulatory pathways largely via peroxisome proliferator-activated receptor alpha-independent mechanisms. , 2002, Cellular signalling.
[24] B. Lake,et al. Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[25] M. Shin,et al. Effects of peroxisome-proliferators on the TRP-NAD pathway. , 1999, Advances in experimental medicine and biology.
[26] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[27] B. Lake,et al. Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium , 1991 .
[28] Y. Egashira,et al. Suppression of Rat Hepatic α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Activity by Linoleic Acid in Relation to Its Induction by Glucocorticoids and Dietary Protein , 1994 .
[29] Andrew W Nicholls Jeremy K Nicholson John N Haseld. A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study. , 2000, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[30] N. Iwamoto,et al. Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets. , 1998, Biochemical pharmacology.
[31] K. Shibata,et al. Elucidation of the Toxic Mechanism of the Plasticizers, Phthalic Acid Esters, Putative Endocrine Disrupters: Effects of Dietary Di(2-ethylhexyl)phthalate on the Metabolism of Tryptophan to… , 2002, Bioscience, biotechnology, and biochemistry.
[32] H. Wolf. Studies on Tryptophan Metabolism in Man: The Effect of Hormones and Vitamin B6 on Urinary Excretion of Metabolites of the Kynurenine Pathway: Part 2 , 1974 .
[33] H. Wolf. The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. , 1974, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[34] N. Lalwani,et al. Induction of hepatic peroxisome proliferation in nonrodent species, including primates. , 1984, The American journal of pathology.
[35] P. Novikoff,et al. Catalase-negative peroxisomes: transient appearance in rat hepatocytes during liver regeneration after partial hepatectomy. , 1995, The American journal of pathology.
[36] J. Biollaz,et al. Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. , 2001, Journal of pharmaceutical and biomedical analysis.
[37] F J Gonzalez,et al. Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice. , 2000, Molecular pharmacology.
[38] J. Lehmann,et al. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. , 1998, Journal of medicinal chemistry.
[39] B. Lake. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. , 1995, Annual review of pharmacology and toxicology.
[40] P J Sadler,et al. Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. , 1989, Molecular pharmacology.
[41] Y. Egashira,et al. Effects of Various Dietary Fatty Acids on α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase Activity in Rat Liver , 1992 .
[42] Y. Egashira,et al. Dietary linoleic acid alters alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD), a key enzyme of niacin synthesis from tryptophan, in the process of protein expression in rat liver. , 1998, Journal of nutritional science and vitaminology.
[43] R. Cuomo,et al. The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production , 2001, American Journal of Gastroenterology.
[44] Brian C Sweatman,et al. Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. , 2002, Journal of pharmaceutical and biomedical analysis.
[45] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[46] M. Shin,et al. Effect of Thioridazine or Chlorpromazine on Increased Hepatic NAD+ Level in Rats Fed Clofibrate, a Hypolipidaemic Drug , 1998, The Journal of pharmacy and pharmacology.